Abiopharma

New Form 10-Q - PMV Pharmaceuticals, Inc. Filed: 2025-08-07 AccNo: 0000950170-25-104588 Size: 8 MB

Prime Medicine Reports Second Quarter 2025 Financial Results and Provides Business Updates

Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 11, 2025

PepGen Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Addus HomeCare Names Heather Dixon President and Chief Operating Officer

Belite Bio Announces Registered Direct Offering of $15 Million

RAPT Therapeutics Reports Second Quarter 2025 Financial Results

Bausch Health Notification

New Form 8-K - PMV Pharmaceuticals, Inc. Filed: 2025-08-07 AccNo: 0000950170-25-104587 Size: 326 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Rallybio Reports Second Quarter 2025 Financial Results and Provides Business Updates

New Form 10-Q - PepGen Inc. Filed: 2025-08-07 AccNo: 0001193125-25-174979 Size: 8 MB

Trinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service

Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL

Daré Bioscience to Host Second Quarter 2025 Financial Results and Company Update Conference Call and Webcast on August 14, 2025

Replimune Reports Fiscal First Quarter 2026 Financial Results and Provides Corporate Update